Cargando…
Clinical significance of 4 patients with chronic hepatitis B achieving HBsAg clearance by treated with pegylated interferon alpha-2a for less than 1 year: a short report
We report 4 chinese patients with hepatitis B e antigen-positive chronic hepatitis B achieving clearance of HBsAg by using pegylated interferon alpha-2a for less than 1 year, to provide one clinical clue for the treatment of chronic hepatitis B.
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714489/ https://www.ncbi.nlm.nih.gov/pubmed/19583877 http://dx.doi.org/10.1186/1743-422X-6-97 |
_version_ | 1782169676286001152 |
---|---|
author | Yang, Jin Zhao, Lian-san |
author_facet | Yang, Jin Zhao, Lian-san |
author_sort | Yang, Jin |
collection | PubMed |
description | We report 4 chinese patients with hepatitis B e antigen-positive chronic hepatitis B achieving clearance of HBsAg by using pegylated interferon alpha-2a for less than 1 year, to provide one clinical clue for the treatment of chronic hepatitis B. |
format | Text |
id | pubmed-2714489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27144892009-07-24 Clinical significance of 4 patients with chronic hepatitis B achieving HBsAg clearance by treated with pegylated interferon alpha-2a for less than 1 year: a short report Yang, Jin Zhao, Lian-san Virol J Short Report We report 4 chinese patients with hepatitis B e antigen-positive chronic hepatitis B achieving clearance of HBsAg by using pegylated interferon alpha-2a for less than 1 year, to provide one clinical clue for the treatment of chronic hepatitis B. BioMed Central 2009-07-08 /pmc/articles/PMC2714489/ /pubmed/19583877 http://dx.doi.org/10.1186/1743-422X-6-97 Text en Copyright © 2009 Yang and Zhao; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Report Yang, Jin Zhao, Lian-san Clinical significance of 4 patients with chronic hepatitis B achieving HBsAg clearance by treated with pegylated interferon alpha-2a for less than 1 year: a short report |
title | Clinical significance of 4 patients with chronic hepatitis B achieving HBsAg clearance by treated with pegylated interferon alpha-2a for less than 1 year: a short report |
title_full | Clinical significance of 4 patients with chronic hepatitis B achieving HBsAg clearance by treated with pegylated interferon alpha-2a for less than 1 year: a short report |
title_fullStr | Clinical significance of 4 patients with chronic hepatitis B achieving HBsAg clearance by treated with pegylated interferon alpha-2a for less than 1 year: a short report |
title_full_unstemmed | Clinical significance of 4 patients with chronic hepatitis B achieving HBsAg clearance by treated with pegylated interferon alpha-2a for less than 1 year: a short report |
title_short | Clinical significance of 4 patients with chronic hepatitis B achieving HBsAg clearance by treated with pegylated interferon alpha-2a for less than 1 year: a short report |
title_sort | clinical significance of 4 patients with chronic hepatitis b achieving hbsag clearance by treated with pegylated interferon alpha-2a for less than 1 year: a short report |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714489/ https://www.ncbi.nlm.nih.gov/pubmed/19583877 http://dx.doi.org/10.1186/1743-422X-6-97 |
work_keys_str_mv | AT yangjin clinicalsignificanceof4patientswithchronichepatitisbachievinghbsagclearancebytreatedwithpegylatedinterferonalpha2aforlessthan1yearashortreport AT zhaoliansan clinicalsignificanceof4patientswithchronichepatitisbachievinghbsagclearancebytreatedwithpegylatedinterferonalpha2aforlessthan1yearashortreport |